Delivery Order SPE2DB22D2009-SPE2DB25FL9AW
Award Date
5/1/25
Potential Completion Date
5/2/25
Potential Value
$261K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the vaccine product MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, with a ceiling value of $31,521.00 and a performance period through April 2025. The contract is a firm-fixed price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MENVEO, a vaccine for the prevention of meningococcal disease. The contract has a ceiling value of $13,704.50 and a period of performance through July 30, 2024. It is a firm-fixed-price contract, and there is no set-aside designation. Amerisourcebergen, through its extensive supply chain network, will provide this critical vaccine...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $158,462.40, is for the procurement of Menveo, a meningococcal conjugate vaccine, and has a period of performance through March 28, 2025. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a larger...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 0.5 ml vials of the Menveo A-C-Y-W-135 Diphtheria CRM197 Conjugate Vaccine. The $31,029.48 firm-fixed-price contract has a period of performance through July 2024. This award is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026,...
This is a $85,597.75 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of Menveo, a vaccine for meningococcal disease, in 0.5 ml vials. The contract has an ultimate completion date of July 3, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The company...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of the Menveo vaccine. The contract has a ceiling value of $5,201.51 and a period of performance through August 28, 2024. AmerisourceBergen is providing this critical vaccine product to support military treatment facilities and other federal healthcare programs. The contract was awarded on a firm-fixed-price basis and does not...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,305.75, is for the delivery of Menveo, a meningococcal vaccine, with a completion date of November 6, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $16,084.50 firm fixed-price contract is for the supply of the Menveo vaccine, a meningococcal vaccine, with a completion date of September 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MENVEO vaccine, a meningococcal conjugate vaccine, with a ceiling value of $63,175.00 and a period of performance through February 5, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $57,926.88, is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has a firm fixed price and is set to be completed by March 25, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...